• Type 2 DM:
    • PO 10mg/100mg OD 
    • The dose may be increased to 25mg/100mg OD.
    • Max 25mg/100mg per day.

Tablet:

  • 10mg/100mg
  • 25mg/100mg
  • Take orally once daily in the morning, with or without food.
  • Hydration is important to avoid dehydration due to the increased urine output from empagliflozin.
  • Empagliflozin (SGLT2 Inhibitor): It lowers blood glucose by inhibiting glucose reabsorption in the kidneys, promoting the excretion of glucose in the urine.
  • Sitagliptin (DPP-4 Inhibitor): It increases incretin hormones (GLP-1 and GIP) which promote insulin secretion and reduce glucagon levels, helping to manage blood glucose.
  • Increased urination
  • UTI
  • Genital infections
  • Dehydration
  • Upper respiratory tract infections
  • Headaches
  • Nasopharyngitis
  • Severe renal impairment
  • Hypersensitivity to components
  • Diabetic ketoacidosis
  • Rifampin
  • Phenytoin
  • Carbamazepine
  • ACE inhibitors
  • ARBs
  • Diuretics

                                   Drug Status

Availability Prescription only
Pregnancy  Not recommended
Breastfeeding  Not recommended
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Empasita 10mg/50mg Tablet 28’s Pharmaken Ltd Pharmaken Ltd